SG Americas Securities LLC boosted its stake in Encompass Health Corporation (NYSE:EHC – Free Report) by 21.8% during the 1st quarter, HoldingsChannel reports. The fund owned 107,288 shares of the company’s stock after buying an additional 19,234 shares during the period. SG Americas Securities LLC’s holdings in Encompass Health were worth $10,378,000 as of its most recent SEC filing.
Other hedge funds also recently added to or reduced their stakes in the company. Royal Bank of Canada increased its position in shares of Encompass Health by 21.5% in the 1st quarter. Royal Bank of Canada now owns 88,470 shares of the company’s stock worth $8,960,000 after purchasing an additional 15,677 shares during the last quarter. Millennium Management LLC grew its stake in Encompass Health by 38.4% in the first quarter. Millennium Management LLC now owns 92,197 shares of the company’s stock worth $9,338,000 after purchasing an additional 25,574 shares in the last quarter. Caxton Associates LLP bought a new stake in Encompass Health in the first quarter valued at about $259,000. Walleye Capital LLC raised its stake in Encompass Health by 667.6% during the second quarter. Walleye Capital LLC now owns 6,522 shares of the company’s stock valued at $800,000 after buying an additional 7,671 shares in the last quarter. Finally, Gamco Investors INC. ET AL bought a new position in Encompass Health during the 2nd quarter worth approximately $588,000. 97.25% of the stock is owned by institutional investors and hedge funds.
Encompass Health Stock Performance
Shares of EHC opened at $101.33 on Friday. The firm has a market capitalization of $10.05 billion, a PE ratio of 16.92, a P/E/G ratio of 2.17 and a beta of 0.72. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.76. The firm has a 50-day moving average price of $103.25 and a 200 day moving average price of $103.60. Encompass Health Corporation has a 52-week low of $92.77 and a 52-week high of $127.99.
Encompass Health Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be issued a dividend of $0.19 per share. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $0.76 annualized dividend and a yield of 0.8%. Encompass Health’s payout ratio is presently 12.69%.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently weighed in on EHC shares. Weiss Ratings reiterated a “buy (b-)” rating on shares of Encompass Health in a report on Monday, June 8th. Leerink Partners set a $152.00 price objective on shares of Encompass Health in a report on Friday, May 22nd. TD Cowen started coverage on shares of Encompass Health in a research note on Thursday, May 28th. They set a “buy” rating and a $125.00 target price for the company. Wall Street Zen raised shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Finally, Barclays decreased their price target on shares of Encompass Health from $153.00 to $140.00 and set an “overweight” rating for the company in a report on Tuesday, May 5th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $143.86.
Check Out Our Latest Report on Encompass Health
Insiders Place Their Bets
In other Encompass Health news, EVP Patrick William Tuer sold 682 shares of the stock in a transaction on Monday, May 11th. The stock was sold at an average price of $104.56, for a total transaction of $71,309.92. Following the completion of the transaction, the executive vice president directly owned 24,755 shares of the company’s stock, valued at approximately $2,588,382.80. This trade represents a 2.68% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.80% of the stock is owned by company insiders.
Encompass Health Profile
Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.
Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.
Read More
- Five stocks we like better than Encompass Health
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
- Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHC – Free Report).
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.
